Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting session of use of fifth generation cephalosporins in treating complicated skin and soft tissue infections (cSSTIs). In this webinar, the speakers, Dr. Atul Mishra and Dr. Neha Gupta has shared the important facts associated with the management of cSSTIs.
Antibiotic resistance is the most common threat that the infectious diseases specialists need to deal with. The emergence of different multi antibiotic resistant infectious strains are threatening the treatment approaches.
Complicated skin and soft tissue infections (cSSTIs) typically involve deep soft tissues. It is mostly observed in patients with underlying disease and it often requires intravenous antibiotic therapy, surgical intervention, or both. The situation of cSSTIs becomes worse when it is accompanied by MRSA infection.
Fifth generation cephalosporin, Ceftobiprole. possesses anti-pseudomonal activity and appears to be less susceptible to development of resistance. Further, it can also treat infections that are resistant to other antibiotics, including MRSA infections.
Therefore, have an overall knowledge on cSSTIs management using fifth generation cephalosporin from different case presentations. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
2.
Research uncovers hidden Australian skin cancer epidemic
3.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
4.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
5.
The American College of Physicians updated its recommendations for colorectal cancer screening.
1.
Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options
2.
The Role of Alanine Aminotransferase in Liver Health and Disease
3.
Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part V
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation